Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2014
12/10/2014CN103214570B 特异于流感病毒h5亚型或者n1亚型的血凝素和神经氨酸酶的单克隆抗体及其应用 H5 specific for influenza virus subtype or subtypes n1 hemagglutinin and neuraminidase monoclonal antibody and its application
12/10/2014CN103209993B 针对赋予对2,4-二氯苯氧乙酸的抗性的酶的单克隆抗体和检测方法 Monoclonal antibodies and detection methods for conferring resistance to 2,4-dichlorophenoxyacetic acid enzyme
12/10/2014CN103204935B 具有改变的细胞信号传导活性的修饰的抗原结合分子 Cells with altered signal transduction activity of modified antigen binding molecule
12/10/2014CN103191157B 一种提高畜禽免疫功能的蜂胶黄酮脂质体及其制备方法 Method for improving livestock immune function propolis liposomes and its preparation method
12/10/2014CN103172735B 抗-系统asc氨基酸转运蛋白2(asct2)抗体 Anti - System asc amino acid transporter 2 (asct2) antibody
12/10/2014CN103157102B 一种制备鸭出血性卵巢炎灭活疫苗的方法 A method of duck hemorrhagic ovarian inflammation inactivated vaccines prepared
12/10/2014CN103083663B 一种免疫增强剂、灭活疫苗及其制备方法 An immune enhancer, inactivated vaccine and its preparation method
12/10/2014CN103073620B Kdr肽和包括该肽的疫苗 Kdr peptides and vaccines comprising the peptide
12/10/2014CN103041387B 恶性b细胞淋巴瘤抗体药物的新用途 B-cell lymphoma malignant new antibody drug use
12/10/2014CN103014056B 一种猪Ⅱ型细环病毒TTSuV2-ORF1截短蛋白的酵母表达及应用 Pig virus type Ⅱ fine ring TTSuV2-ORF1 truncated protein expression in yeast and Applications
12/10/2014CN102921007B 防治胰岛素抵抗和糖尿病的方法和试剂 Insulin resistance and diabetes prevention methods and reagents
12/10/2014CN102884079B 治疗肝炎病毒感染的组合物及方法 Therapeutic compositions and methods for hepatitis virus infection
12/10/2014CN102863514B 用于表达肿瘤相关抗原的癌症的肽疫苗 Peptide vaccine for the expression of tumor-associated antigens of cancer
12/10/2014CN102821785B 生产过敏原提取物的方法 Production method allergen extract
12/10/2014CN102796200B 一种杂合肽囊素佐剂及其制备方法和应用 A hybrid Bursin adjuvant and its preparation method and application
12/10/2014CN102781962B 双互补位A-β结合多肽 Pairs of complementary bit A-β binding polypeptide
12/10/2014CN102732608B 一种诊断肝癌的标记物及其应用 A method of diagnosing liver cancer marker Its Applications
12/10/2014CN102580082B 一种禽用灭活疫苗及其制备方法 One kind of poultry with inactivated vaccine and its preparation method
12/10/2014CN102321626B 用于抑制蛋白激酶3表达的方法 Method for inhibiting the expression of protein kinase 3
12/10/2014CN102268090B 一种暹罗鳄血液提取物及其提取方法和用途 One kind of Siamese crocodile blood extract and extraction methods and uses
12/10/2014CN102105163B 氯霉素乙酰转移酶(cat)-缺陷型促生长素抑制素融合蛋白及其用途 Chloramphenicol acetyltransferase (cat) - deficient somatostatin fusion protein and its use
12/10/2014CN102089002B 稳定剂和含一种或多种减毒活黄病毒的疫苗组合物 Stabilizers and containing one or more live attenuated flavivirus vaccine composition
12/10/2014CN102015769B 改进的抗-trkb抗体 Improved resistance -trkb antibody
12/10/2014CN102014957B 用于治疗耳部疾病和病况的耳用调配物 Otic formulation for the treatment of otic diseases and conditions
12/10/2014CN101993478B Eb病毒潜伏膜蛋白2多表位重组蛋白及应用 Eb virus latent membrane protein 2 multi-epitope recombinant proteins and application
12/10/2014CN101951946B 结合间皮素的人抗体及其应用 Mesothelin binding between human antibodies and their application
12/10/2014CN101861164B 朊病毒蛋白相关疾病的治疗 Treatment of a disease associated prion protein
12/10/2014CN101842490B 抗原组合物及其在核酸的靶向递送中的应用 Antigen composition and its application in the targeted delivery of nucleic acids
12/10/2014CN101721702B 用于治疗TNF-α相关疾病的人抗体的制剂 For the treatment of TNF-α-related diseases of a human antibody preparation
12/10/2014CN101065151B 半胱氨酸改造的抗体和偶联物 Cysteine ​​engineered antibody and conjugate
12/10/2014CN101022828B B因子、补体旁路的抑制及与此相关的方法 B factor, and inhibition of complement pathway associated with this method
12/09/2014US8909483 Direct or indirect diagnostic test for helminth infection
12/09/2014US8907163 Transgenic plants expressing galactosyltransferase and sialyl transferase
12/09/2014US8907072 Nucleic acids encoding antibody 137-26 which binds C5 and C5a
12/09/2014US8907069 Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent
12/09/2014US8907068 Anti-IL-20 antibodies and binding partners and methods of using in inflammation
12/09/2014US8907066 Antibody fusion proteins with a modified FcRn binding site
12/09/2014US8907065 Polypeptides that modulate the interaction between cells of the immune system
12/09/2014US8907060 Mutated Pseudomonas exotoxins with reduced antigenicity
12/09/2014US8906863 Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector
12/09/2014US8906862 Multiple antigen delivery system using hepatitis E virus-like particle
12/09/2014US8906857 Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
12/09/2014US8906847 Prodrug comprising a drug linker conjugate
12/09/2014US8906682 Methods for treatment of cancer
12/09/2014US8906664 Methods for constructing antibiotic resistance free vaccines
12/09/2014US8906630 Assays for detecting pathogenic respiratory bacteria
12/09/2014US8906619 HDV nucleic acid molecules, fragments and applications thereof
12/09/2014US8906602 Methods for identifying candidate compounds for treating, reducing, or preventing pathogenic infections
12/09/2014US8906389 Determination of the efficacy of an anti-mycobacterial vaccination
12/09/2014US8906388 Methods for detecting Mycobacterium tuberculosis antigens
12/09/2014US8906387 In vivo transduction with a chimeric AAV capsid protein
12/09/2014US8906386 Mutant proteins of the F protein of PIV-5 and PIV-2
12/09/2014US8906385 Interferon-inducing porcine reproductive and respiratory syndrome virus isolate
12/09/2014US8906384 Antiviral activity of bovine type III interferon against foot-and-mouth disease virus
12/09/2014US8906383 T cell receptor having binding affinity for a peptide-MHC complex and uses thereof
12/09/2014US8906382 Method for treating amyloid disease
12/09/2014US8906381 Immunonanotherapeutics that provide IGG humoral response without T-cell antigen
12/09/2014US8906380 Fungal immunostimulatory compositions
12/09/2014US8906379 Targeting of glycoprotein therapeutics
12/09/2014US8906378 Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
12/09/2014US8906377 Stably tethered structures of defined compositions with multiple functions or binding specificities
12/09/2014US8906375 Methods of using antibodies against human IL-22
12/09/2014US8906374 Combination therapy with CD4 lymphocyte depletion and mTOR inhibitors
12/09/2014US8906373 Use of TNF-alpha inhibitor for treatment of psoriasis
12/09/2014US8906372 Purified antibody composition
12/09/2014US8906371 Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors
12/09/2014US8906370 Antibodies against amyloid beta 4 with glycosylation in the variable region
12/09/2014US8906369 Ovr110 antibody compositions and methods of use
12/09/2014US8906368 Immunoglobulin preparations having increased stability
12/09/2014US8906367 Method of providing disease-specific binding molecules and targets
12/09/2014US8906358 Leishmania challenge model
12/09/2014US8906342 Compositions against cancer antigen LIV-1 and uses thereof
12/04/2014US20140357845 Influenza virus vaccines and uses thereof
12/04/2014US20140357510 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt
12/04/2014US20140356435 Hydrophobic Drug-Delivery Material, Method For Manufacturing Thereof And Methods For Delivery Of A Drug-Delivery Composition
12/04/2014US20140356421 Antibody-Conjugated Double-Emulsion Nanocapsule and Preparation Methods Thereof
12/04/2014US20140356415 Compositions and vaccines comprising vesicles and methods of using the same
12/04/2014US20140356399 Compositions and methods for treating viral infections
12/04/2014US20140356397 Immunogenic Treatment Of Cancer
12/04/2014US20140356396 Rotavirus preparations with excess calcium ions and high viscosities that ensure viability at elevated temperatures
12/04/2014US20140356395 Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance
12/04/2014US20140356392 Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
12/04/2014US20140356391 Amino acid sequences for clinical remission of psoriasis and related diseases.
12/04/2014US20140356390 Modulation of replicative fitness by deoptimization of synonymous codons
12/04/2014US20140356389 Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
12/04/2014US20140356388 Vaccine - Screening Method
12/04/2014US20140356387 Method for inducing immune tolerance through targetted gene expression
12/04/2014US20140356386 Immunization protocol for directed expansion and maturation
12/04/2014US20140356382 Exosomes for Delivery of Biotherapeutics
12/04/2014US20140356380 Neutralizing Antibodies And Methods Of Use Thereof
12/04/2014US20140356376 Anti-wall teichoic antibodies and conjugates
12/04/2014US20140356375 Anti-wall teichoic antibodies and conjugates
12/04/2014US20140356372 Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
12/04/2014US20140356371 Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (pcsk9)
12/04/2014US20140356367 Monophosphorylated lipid a derivatives
12/04/2014US20140356361 Repeated administration of non-immunosuppressive antigen specific immunotherapeutics
12/04/2014US20140356355 Il-17 receptor a antigen binding proteins
12/04/2014US20140356352 COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79b ANTIBODY-DRUG CONJUGATE
12/04/2014US20140356350 Combination therapy to prevent dcis formation and progression to breast cancer
12/04/2014US20140356349 Biomarkers of resistance to her2 inhibitors
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 1823